In our study, we developed an in-house CD9 ELISA assay to quantify CD9+ sEVs, and the results demonstrated that salivary CD9 expression and salivary CD9+ sEVs were comparable between healthy, gingivitis and periodontitis groups, which was in line with Chaparro Padilla et al. [17]. This evidence concerns the gene CD9 and periodontitis.